{"id":47852,"date":"2006-09-01T00:00:00","date_gmt":"2018-12-04T03:23:23","guid":{"rendered":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/"},"modified":"2018-12-04T04:23:23","modified_gmt":"2018-12-04T03:23:23","slug":"low-dose-folic-acid-supplementation-reduces-homocysteine","status":"publish","type":"resume","link":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/","title":{"rendered":"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients"},"content":{"rendered":"<p>Document Type: Article<br \/>\nLanguage: English<br \/>\nAbstract: Whether patients with coronary artery disease need to supplement their diet with a high dose of folic acid (even if their folate status is adequate) to reduce their plasma homocysteine concentration remains unclear. The purpose of this study was to evaluate the effect of a low oral dose of folic acid on lowering the plasma homocysteine concentration in response to the 5,10-methylenetetrahydrofolate reductase 677 -&gt; T genotypes in patients with coronary artery disease. Patients were randomly assigned to I of 2 groups: a placebo group (n = 22; CC\/CT\/TT = 12\/7\/3) and a folic acid group (400 mu g\/d folate; n = 24; CC\/CT\/TT = 8\/11\/5). Intervention was administered for 2 months (8 weeks). Folic acid supplements did not significantly lower fasting plasma homocysteine concentration after 8 weeks of supplementation. However, low-dose folic acid supplementation (400 mu g\/d) significantly reduced homocysteine by 1.8 mu mol\/L (P &lt; .05) at week 8 for those subjects with hyperhomocysteinemia, especially for carriers of the T-allele. (c) 2006 Elsevier Inc. All rights reserved.<br \/>\nAuthor Keywords: low-dose; folic acid supplementation; homocysteine; methylenetetrahydrofolate reductase; coronary artery disease; humans<br \/>\nKeyWords Plus: METHYLENETETRAHYDROFOLATE REDUCTASE GENOTYPES; HEALTHY-YOUNG WOMEN; PLASMA HOMOCYSTEINE; MYOCARDIAL-INFARCTION; RISK-FACTOR; 5,10-METHYLENETETRAHYDROFOLATE REDUCTASE; ELDERLY POPULATION; VASCULAR-DISEASE; COMMON MUTATION; FOLATE STATUS <\/p>\n","protected":false},"template":"","mots_cles":[],"class_list":["post-47852","resume","type-resume","status-publish","hentry"],"acf":{"adresse":"Addresses: Huang YC (reprint author), Chung Shan Med Univ, Sch Nutr, Taichung 402, Taiwan\r\nChung Shan Med Univ, Sch Nutr, Taichung 402, Taiwan\r\nChung Shan Med Univ, Inst Nutr Sci, Taichung 402, Taiwan\r\nTaichung Vet Gen Hosp, Intens Care Unit, Taichung 400, Taiwan\r\nChung Shan Med Univ Hosp, Dept Clin Lab, Taichung 402, Taiwan\r\nE-mail Addresses: ych@csmu.edu.tw \r\n","annee":"2006","mois":"9","numero":"26:9","page":"460-466","auteurs":[{"ID":11415,"post_author":"0","post_date":"2018-12-03 18:35:02","post_date_gmt":"2018-12-03 17:35:02","post_content":"","post_title":"Yi-Chen Huang","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"yi-chen-huang","to_ping":"","pinged":"","post_modified":"2018-12-03 18:35:02","post_modified_gmt":"2018-12-03 17:35:02","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/yi-chen-huang\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":47848,"post_author":"0","post_date":"2018-12-04 04:23:20","post_date_gmt":"2018-12-04 03:23:20","post_content":"","post_title":"Lin","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"lin-3","to_ping":"","pinged":"","post_modified":"2018-12-04 04:23:20","post_modified_gmt":"2018-12-04 03:23:20","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/lin-3\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":47849,"post_author":"0","post_date":"2018-12-04 04:23:21","post_date_gmt":"2018-12-04 03:23:21","post_content":"","post_title":"Lee","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"lee-15","to_ping":"","pinged":"","post_modified":"2018-12-04 04:23:21","post_modified_gmt":"2018-12-04 03:23:21","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/lee-15\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":19638,"post_author":"0","post_date":"2018-12-03 20:24:14","post_date_gmt":"2018-12-03 19:24:14","post_content":"","post_title":"Hao-Hsiang Chang","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"hao-hsiang-chang","to_ping":"","pinged":"","post_modified":"2018-12-03 20:24:14","post_modified_gmt":"2018-12-03 19:24:14","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/hao-hsiang-chang\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":47850,"post_author":"0","post_date":"2018-12-04 04:23:22","post_date_gmt":"2018-12-04 03:23:22","post_content":"","post_title":"Cheng","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"cheng-3","to_ping":"","pinged":"","post_modified":"2018-12-04 04:23:22","post_modified_gmt":"2018-12-04 03:23:22","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/cheng-3\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"},{"ID":47851,"post_author":"0","post_date":"2018-12-04 04:23:22","post_date_gmt":"2018-12-04 03:23:22","post_content":"","post_title":"Tsai","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"tsai-4","to_ping":"","pinged":"","post_modified":"2018-12-04 04:23:22","post_modified_gmt":"2018-12-04 03:23:22","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/auteur\/tsai-4\/","menu_order":0,"post_type":"auteur_resume","post_mime_type":"","comment_count":"0","filter":"raw"}],"sources":[{"ID":43958,"post_author":"0","post_date":"2018-12-04 03:15:19","post_date_gmt":"2018-12-04 02:15:19","post_content":"","post_title":"NUTRITION RESEARCH","post_excerpt":"","post_status":"publish","comment_status":"closed","ping_status":"closed","post_password":"","post_name":"nutrition-research","to_ping":"","pinged":"","post_modified":"2018-12-04 03:15:19","post_modified_gmt":"2018-12-04 02:15:19","post_content_filtered":"","post_parent":0,"guid":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/source\/nutrition-research\/","menu_order":0,"post_type":"source","post_mime_type":"","comment_count":"0","filter":"raw"}]},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.6 (Yoast SEO v23.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients - Aprifel<\/title>\n<meta name=\"description\" content=\"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients - Aprifel\" \/>\n<meta name=\"robots\" content=\"noindex, follow\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients\" \/>\n<meta property=\"og:description\" content=\"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients\" \/>\n<meta property=\"og:url\" content=\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/\" \/>\n<meta property=\"og:site_name\" content=\"Aprifel\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/\",\"url\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/\",\"name\":\"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients - Aprifel\",\"isPartOf\":{\"@id\":\"https:\/\/www.aprifel.com\/fr\/#website\"},\"datePublished\":\"2018-12-04T03:23:23+00:00\",\"dateModified\":\"2018-12-04T03:23:23+00:00\",\"description\":\"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients - Aprifel\",\"breadcrumb\":{\"@id\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.aprifel.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"R\u00e9sum\u00e9s\",\"item\":\"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.aprifel.com\/fr\/#website\",\"url\":\"https:\/\/www.aprifel.com\/fr\/\",\"name\":\"Aprifel\",\"description\":\"Agence pour la Recherche et l\u2019Information en Fruits et L\u00e9gumes\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.aprifel.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients - Aprifel","description":"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients - Aprifel","robots":{"index":"noindex","follow":"follow"},"og_locale":"fr_FR","og_type":"article","og_title":"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients","og_description":"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients","og_url":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/","og_site_name":"Aprifel","twitter_card":"summary_large_image","twitter_misc":{"Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/","url":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/","name":"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients - Aprifel","isPartOf":{"@id":"https:\/\/www.aprifel.com\/fr\/#website"},"datePublished":"2018-12-04T03:23:23+00:00","dateModified":"2018-12-04T03:23:23+00:00","description":"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients - Aprifel","breadcrumb":{"@id":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/low-dose-folic-acid-supplementation-reduces-homocysteine\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.aprifel.com\/fr\/"},{"@type":"ListItem","position":2,"name":"R\u00e9sum\u00e9s","item":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/resume-scientifique\/"},{"@type":"ListItem","position":3,"name":"Low-dose folic acid supplementation reduces homocysteine concentration in hyperhomocysteinemic coronary artery disease patients"}]},{"@type":"WebSite","@id":"https:\/\/www.aprifel.com\/fr\/#website","url":"https:\/\/www.aprifel.com\/fr\/","name":"Aprifel","description":"Agence pour la Recherche et l\u2019Information en Fruits et L\u00e9gumes","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.aprifel.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"}]}},"_links":{"self":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/resume\/47852"}],"collection":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/resume"}],"about":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/types\/resume"}],"wp:attachment":[{"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/media?parent=47852"}],"wp:term":[{"taxonomy":"mots_cles","embeddable":true,"href":"https:\/\/aprifel-pp.mentalworks.biz\/fr\/wp-json\/wp\/v2\/mots_cles?post=47852"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}